                         SEQUENCE LISTING

<110>  Galderma Research & Development
       Centre national de la recherche scientifique
       Universit d'Aix-Marseille
 
<120>  Anticorps dirigs contre le canal sodique Nav1.9 humain et leurs 
       utilisations en diagnostic

<130>  B1638PC00

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fragment de hNav1.9

<400>  1

Ile Ala Ile Gln Lys Glu Lys Lys Lys Ser Lys Asp Gln Thr Gly Glu 
1               5                   10                  15      


Val 
    


<210>  2
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fragment de hNav1.9

<400>  2

Glu Ser Gly Lys Asp Gln Pro Pro Gly Ser Asp Ser Asp Glu Asp Cys 
1               5                   10                  15      


<210>  3
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fragment de hNav1.9

<400>  3

Gln Ala Tyr Glu Leu His Gln Glu Asn Lys Lys Pro Thr Ser Gln Arg 
1               5                   10                  15      


Val 
    


<210>  4
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Fragment de hNav1.9

<400>  4

Ser Asn Glu Glu Arg Asn Gly Asn Leu Glu Gly Glu Ala Arg Lys 
1               5                   10                  15  


